- Home
- TLIH vs ESLA Comparison
TLIH vs ESLA Comparison
Compare TLIH & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLIH | ESLA |
|---|---|---|
| Founded | 1998 | 2021 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2M | 19.1M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TLIH | ESLA |
|---|---|---|
| Price | $5.68 | $0.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.2K | ★ 3.9M |
| Earning Date | 09-30-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.34 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $0.24 |
| 52 Week High | $6.08 | $3.01 |
Technical Indicators
Market Signals| Indicator | TLIH | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 44.35 | 41.78 |
| Support Level | $5.22 | $0.34 |
| Resistance Level | $5.90 | $0.51 |
| Average True Range (ATR) | 0.37 | 0.20 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 81.05 | 19.56 |
Price Performance
Historical ComparisonAbout TLIH Ten-League International Holdings Limited Ordinary Shares
Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental, and provision of engineering consultancy services to port, construction, civil engineering, and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment, and port machinery. The company operates in Singapore and Other international countries.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.